Gnaphalium Polycephalum
Product Images NDC 15631-0592

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Gnaphalium Polycephalum (NDC 15631-0592). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (15631 0592)

Image Description (15631 0592)
This is a description for a medication named "1X". The ingredients include lactose and an active ingredient that is not listed. The medication is used to treat sciatica. It is available as tablets that should be taken orally, and the recommended dosage is 4 or 6 tablets three times a day. The product can be used for self-limiting conditions, but if the symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance from a health professional. The medication should be kept in a cool and dark place, out of children's reach, and not used if the capsule is broken or missing. The manufacturer is Rxhomeo Private Limited, located in Hyderabad, India, and distributed in the US by Rxhomeo, Inc, located in Texas. There is a lot of unreadable text at the end of the description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.